(Q34778942)

4 August 2017

1 reference

title

Managing dyspnea and cough (English)

1 reference

4 August 2017

Deborah J Dudgeon

1

1 reference

4 August 2017

publication date

1 June 2002

1 reference

Hematology / Oncology Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

16

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

557-77, viii

1 reference

The experience of breathlessness in lung cancer.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The experience of dyspnea in late-stage cancer Patients?? and nurses?? perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dyspnea. Pathophysiologic basis, clinical presentation, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dyspnea in cancer patients: prevalence and associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dyspnea in terminally ill cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The impact of home palliative care on symptoms in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The frequency and correlates of dyspnea in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dyspnea in the advanced cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Physiological changes and clinical correlations of dyspnea in cancer outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The shuttle walking test: a reproducible method for evaluating the impact of shortness of breath on functional capacity in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Reading numbers aloud: a measure of the limiting effect of breathlessness in patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Does spirometry predict dyspnoea in advanced cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dyspnea in cancer patients: Etiology, resource utilization, and survival-Implications in a managed care world

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Surgical palliation of airway obstruction resulting from lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Management of malignant pleural effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The treatment of malignant pleural effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Indwelling small pleural catheter needle thoracentesis in the management of large pleural effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Malignant pleural effusions: recent advances and ambulatory sclerotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Recombinant tumour necrosis factor in the local therapy of malignant pleural effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Treating malignant pleural effusions cost consciously

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Diagnosis and management of malignant pleural effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Malignant effusive disease of the pleura and pericardium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Pericardioperitoneal shunt: an alternative treatment for malignant pericardial effusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Safety and efficacy of thrombolytic therapy for superior vena cava syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Pulmonary Effects of Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Pulmonary radiation injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The impact of exercise reconditioning on breathlessness in severe chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The effects of refeeding on peripheral and respiratory muscle function in malnourished chronic obstructive pulmonary disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Respiratory acidosis. I. Effects of decreasing respiratory minute volume in patients with severe chronic pulmonary emphysema, with specific reference to oxygen, morphine and barbiturates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Breathlessness, Alcohol, and Opiates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Subcutaneous morphine for dyspnea in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of morphine on the dyspnea of terminal cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Management of dyspnea and cough in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Dihydrocodeine for breathlessness in "pink puffers".

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of Dihydrocodeine, Alcohol, and Caffeine on Breathlessness and Exercise Tolerance in Patients with Chronic Obstructive Lung Disease and Normal Blood Gases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Continuous intravenous infusion of morphine for severe dyspnea.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Low-dose nebulized morphine does not improve exercise in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Chlorpromazine--a specific effect on breathlessness?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The use of chlorpromazine for symptom control in dying cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Control of dyspnea in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The effect of indomethacin on breathlessness in patients with diffuse parenchymal disease of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Indomethacin and perception of dyspnea in chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anaesthetic aerosol inhalation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

The effect of airway anaesthesia on the control of breathing and the sensation of breathlessness in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Long-term management of respiratory symptoms in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Long-term oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

OXYGEN RELIEVES BREATHLESSNESS IN "PINK PUFFERS"

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Does oxygen help dyspnea in patients with cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Controlled trial of acupuncture for disabling breathlessness.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Acupressure as an adjunct to a pulmonary rehabilitation program

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Acupuncture for the relief of cancer-related breathlessness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Breathlessness and psychiatric morbidity in chronic bronchitis and emphysema: a study of psychotherapeutic management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Non-pharmacological intervention for breathlessness in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of guided imagery in patients with chronic bronchitis and emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effect of therapeutic touch on the well-being of persons with terminal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Cold facial stimulation reduces breathlessness induced in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Reducing ventilatory response to carbon dioxide by breathing cold air.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Effects of nasal cold receptors on pattern of breathing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Physiology and treatment of cough

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

An approach to cough in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Benzonatate for opioid-resistant cough in advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Antitussive properties of inhaled bronchodilators on induced cough

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

Lignocaine aerosol and persistent cough

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2802%2900019-9

7 January 2021

10.1016/S0889-8588(02)00019-9

Identifiers

DOI

1 reference

4 August 2017

1 reference